GenePlanet Presents its Innovative Health Platform at MEDICA 2018

GenePlanetGenePlanet, the Swiss-backed biotech company present in more than 30 countries worldwide, is attending MEDICA, the leading international trade fair for the medical sector that takes place in Düsseldorf, Germany, from 12-15 November. "Our participation at MEDICA represents a great opportunity to introduce our solutions to a highly-qualified audience. The most important asset people have is their health. We believe GenePlanet can greatly contribute to empowering them to take action to live a healthier lifestyle," commented Marko Bitenc, GenePlanet's CEO.

The company's key innovation is Health Intelligence (Hi!) - a health engagement platform integrating biological data (genetic predispositions, the current status of blood biomarkers and microbiome data) with information from smart devices and wearables to provide recommendations and action plans to improve one’s health and lifestyle.

By setting personal goals and challenges, the user will be able to monitor their progress in specific areas such as nutrition & diet, training & sports, skincare and mental well-being to facilitate long-term behavioural changes that lead to better overall health.

During the event, GenePlanet will also present its successful flagship product, NutriFit - one of the most important players in the field of Nutrigenomics and NutriSkin - a DNA test for personalised skincare and rejuvenation. The company will also show a non-invasive prenatal testing based on cell-free foetal DNA for detection of Down syndrome and other chromosomal abnormalities (NIPT); an accurate test for more than 600 genetic disorders for future parents (Carrier Screen); a test for 87 genetic disorders & 32 medications (Newborn Screen) and Cancer Screen for hereditary cancer risk assessment.

For further information, please visit:
https://geneplanet.com

About GenePlanet

GenePlanet is specialised in genetic testing and related advanced molecular techniques and recognised for offering personalised DNA analyses. By being R&D oriented, the company constantly strives for new discoveries that enables it to provide its clients with the latest and best products developed from its in-house research and development. GenePlanet was established in 2008 in Slovenia by Marko Bitenc, a Silicon Valley Singularity University alumnum, and has just been recognised as the Exporter of the Year 2018 by the public agency SPIRIT Slovenia.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...